CClinicalTrials.gg
CompletedNCT01060436FaceUpdated Dec 6, 2016

Face of Sleepiness

An observational study in Obstructive Sleep Apnea, sponsored by University of Michigan. Completed at 1 site in United States. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2016-12-06.

Sponsored by University of Michigan · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
30
Ages
18 Years to 65 Years
Sex
All
01

Study summary

The purpose of this pilot study is to find out whether successful treatment of obstructive sleep apnea makes people look less sleepy, for example by reducing swelling or dark circles under the eyes. In addition, this study will help determine whether facial photographs may be used to help identify patients who should be tested for sleep apnea and daytime sleepiness.

Read the detailed description

The main symptom of nocturnal sleep disorders is often excessive daytime sleepiness. Although sleepiness can be a major contributor to decreased quality of life, and even mortality, patients frequently grow habituated to their sleepiness, ignoring it and any underlying disorder. One scarcely explored potential consequence that could motivate patients to address sleep disorders is a sleepy facial appearance. No peer-reviewed literature, to our knowledge, has explored whether inadequate or insufficient sleep actually causes changes facial appearance. No published literature has examined the extent to which treatment for sleep disorders might improve such facial changes, and perhaps motivate patients to treat their sleep disorders.

To address these questions in a preliminary manner, therefore, the investigators propose to use cutting-edge photographic technology to assess subtle changes in facial appearance. The investigators will recruit 20 sleepy adult patients who are diagnosed with obstructive sleep apnea, an ideal disease model in which subjects can be tested before and after alleviation of severe sleepiness by home use of continuous positive airway pressure. Results of this pilot study could show for the first time that successful treatment of a chronic sleep disorder improves facial features commonly perceived as an undesirable sign of sleepiness.

02

Conditions studied

  • Obstructive Sleep Apnea

Keywords

  • sleep apnea
  • sleep disordered breathing
  • CPAP
  • BiPAP
  • treatment outcomes
03

In context

Sleep Apnea Syndromes

2,162 studies on the registry are indexed under Sleep Apnea Syndromes; 291 are open to participants now.

This study's enrollment of 30 is below the median of 109 across 654 observational studies indexed under Sleep Apnea Syndromes.

Browse Sleep Apnea Syndromes studies →

Lead sponsor

University of Michigan is the lead sponsor of 1,475 studies on the registry; 196 are open to participants now.

Of its 162 completed or terminated interventional studies of FDA-regulated products, 128 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

University of Michigan Sleep Disorders Clinic

Inclusion criteria

  • Adults, age 18-65
  • Recently diagnosed with obstructive sleep apnea, confirmed by polysomnography (sleep study)
  • Experiencing daytime sleepiness, based on Epworth Sleepiness Scale
  • Scheduled for a positive airway pressure (PAP) titration study (CPAP or BiPAP)
  • Willing to use CPAP or BiPAP at pressures prescribed by the treating physician
  • Willing to have facial photographs taken before treatment and 2-4 months after nightly use of CPAP or BiPAP

Exclusion criteria

Exclusion Criteria:

  • Diagnosed with other sleep, medical or psychiatric disorders that might limit the effectiveness of PAP treatment (such as morbid obesity, emphysema, and neurodegenerative disorders)
  • Conditions that may cause daytime sleepiness (such as narcolepsy, primary insomnia, seizure disorders, or major depression)
  • Use of medications or herbal remedies that affect sleep and behavior
  • History of facial plastic or reconstructive surgery or Botox injections or plans to undergo these types of treatments prior to completing the second study visit
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
30 participants (actual)

Interventions

  • DeviceCPAP or BiPAP machines

    Nightly use of CPAP or BiPAP at a pressure recommended by the subject's treating physician

06

What researchers measure

Primary outcomes

  1. Photographic assessment of changes in facial indicators of sleepiness (ptosis, flattening or darkening of the external infraorbital surface) after PAP-treatment

    Time frame: 2-4 months after successful nightly use of CPAP or BiPAP

Secondary outcomes

  1. Blinded raters provide visual assessment of relative improvement in facial images of subjects after successful PAP treatment

    Time frame: 2-4 months after successful nightly use of CPAP or BiPAP

07

Study locations

1 site
  • University of Michigan Sleep Disorders Center
    Ann Arbor, Michigan 48109, United States
08

References and documents

Publications

  • Chervin RD, Ruzicka DL, Vahabzadeh A, Burns MC, Burns JW, Buchman SR. The face of sleepiness: improvement in appearance after treatment of sleep apnea. J Clin Sleep Med. 2013 Sep 15;9(9):845-52. doi: 10.5664/jcsm.2976. PubMed 23997695 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 6, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01060436
Lead sponsor
University of Michigan
Responsible party
Ronald D. Chervin, M.D., M.S. (Professor of Neurology and Michael S Aldrich Sleep Collegiate Professor of Sleep Medicine, University of Michigan) — Principal investigator
First posted
Feb 2, 2010
Start date
Feb 2010
Primary completion
Nov 2011
Completion
Aug 2012
Last update
Dec 6, 2016

Study contacts

Ronald D Chervin, MD, MS
principal investigator · University of Michigan

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion